0
Trials
0
+
Sites
0
+
Patients Enrolled
0
Countries
What we do
ANZUP is the leading cancer cooperative clinical trials group that brings together all of the professional disciplines and groups involved in researching and treating below the belt (penile, bladder, kidney, prostate and testicular) cancers and conduct high quality clinical research.
ANZUP identifies gaps in evidence and areas of clinical need,
collaborates with the leading clinicians and researchers in below the
belt cancers, and communicate frequently and effectively with the
broader community along the way.
Join ANZUP
If you are not yet an ANZUP member then join our large multidisciplinary network of urogenital and prostate cancer researchers, clinicians, nurses, psychologists, scientists, allied health and consumer representatives. Membership is free.
If you are a member of the community and would like to learn more about below the belt cancers, then join ‘Friends of ANZUP’.
Trials and Research
All of the major milestones in controlling cancer worldwide have come through clinical trials, but we still have a long way to go to help every person affected, at risk or diagnosed with this disease.
We have clinical trials across each cancer type, in various stages of progress: in activation, open to patient recruitment, in follow up and completed trials.
Telehealth and Teletrials
Teletrials builds on the telehealth model and increases access to clinical trials for people with cancer living in rural and remote locations.
Teleheath and Teletrials
Teletrials builds on the telehealth model and increases access to clinical trials for people with cancer living in rural and remote locations, or in self-isolation due to COVID-19. Teletrials also allows trials recruitment and activity to continue.
One week to go! Join us at Adelaide Oval for an evening featuring highlights from the ANZUP ASM, ASCO GU, ASCO, ESMO and UAA, including the latest management, and clinical trials research in urogenital and prostate cancers. 👉 Last chance to register: https://anzup.org.au/best-of-gu-oncology-evening-symposium/
New findings from the #ENZARAD study presented at #EMSO25, led by @ANZUPtrials with @TrialsCentre, show most #ProstateCancer patients don’t need enzalutamide added to standard care. But in some high-risk cases, enzalutamide may improve metastasis-free survival. Important guidance…
Latest News
ANZUP’s TheraP Trial Reveals How a Simple Blood Test Could Transform Prostate Cancer Treatment
28/05/2025
ANZUP’s TheraP trial has found that certain ‘spelling mistakes’ in prostate cancer DNA found in the blood can reveal hidden weaknesses that make the cancer
New research findings from the ENZA-p study (ANZUP 1901), reveal a world-first combination treatment approach resulted in improvement in both survival and quality of life, for people living with a poor prognosis prostate cancer
14/02/2025
FIRST OF ITS KIND COMBINATION TREATMENT APPROACH IMPROVES SURVIVAL RATES IN AUSTRALIANS WITH METASTATIC PROSTATE CANCER New research findings were reported today from the ENZA-p
Groundbreaking three-year partnership to tackle prostate cancer
10/10/2024
Prostate Cancer Foundation of Australia (PCFA) and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) have agreed to a landmark three-year
ANZUP’s TheraP Trial Reveals How a Simple Blood Test Could Transform Prostate Cancer Treatment
28/05/2025
ANZUP’s TheraP trial has found that certain ‘spelling mistakes’ in prostate cancer DNA found in the blood can reveal hidden weaknesses that make the cancer
New research findings from the ENZA-p study (ANZUP 1901), reveal a world-first combination treatment approach resulted in improvement in both survival and quality of life, for people living with a poor prognosis prostate cancer
14/02/2025
FIRST OF ITS KIND COMBINATION TREATMENT APPROACH IMPROVES SURVIVAL RATES IN AUSTRALIANS WITH METASTATIC PROSTATE CANCER New research findings were reported today from the ENZA-p